Frontlight ResearchEarly access
Trial site
Nanjing
- 9running trials
- 8closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma3 trials
- Asthma2 trials
- COPD2 trials
- Hepatitis B2 trials
- Lupus (SLE)2 trials
- ANCA-associated vasculitis1 trial
- Bronchiectasis1 trial
- Chronic rhinosinusitis with nasal polyps1 trial
- Lung cancer1 trial
- Osteoarthritis1 trial
- Primary biliary cholangitis1 trial
- Systemic sclerosis (scleroderma)1 trial
- Phase
- Phase 312 trials
- Phase 22 trials
- Phase 11 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed7 trials
- Active, not recruiting5 trials
- Recruiting4 trials
- Terminated1 trial
- Lead sponsor
- GlaxoSmithKline17 trials
Running trials
Recruiting
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bronchiectasis1 recruiting
- COPD1 recruiting
- Multiple myeloma1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Closed trials
Terminated
Completed
A Study of Belimumab in Chinese Pediatric Participants With Systemic Lupus Erythematosus
Completed
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026